ANKRD36–Ankrd36 Inhibitors
ANKRD36, or Ankyrin Repeat Domain 36, belongs to a family of proteins that are characterized by the presence of ankyrin repeat motifs. These motifs are involved in protein-protein interactions and have been shown to play critical roles in various cellular processes. The ankyrin repeat domains are usually involved in mediating protein interactions, and ANKRD36 is implicated in modulating specific intracellular pathways related to cellular structure and function. Structurally, ankyrin repeats consist of 33 amino acid residues that form helix-loop-helix structures, which are essential for their role in protein binding. ANKRD36 may act as a scaffold protein, allowing the assembly of multiprotein complexes, thereby influencing various biochemical pathways.
Inhibitors of ANKRD36 target these ankyrin repeat domains and interfere with their ability to facilitate protein-protein interactions. This disruption can lead to alterations in cellular processes, as the ankyrin repeat domains are integral in organizing functional complexes within the cell. ANKRD36 inhibitors could potentially affect various intracellular signaling cascades by preventing these specific interactions, which may influence gene expression, protein stability, or enzymatic activity. These inhibitors are generally designed to bind selectively to the ankyrin repeat domain, altering its conformation or preventing its proper association with other proteins. Studying the molecular mechanisms by which ANKRD36 inhibitors function can provide insights into the broader role of ankyrin repeat proteins in cellular dynamics and their regulation of essential biological processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A broad-spectrum kinase inhibitor which can influence a variety of signaling pathways. If Ankyrin repeat domain-containing protein 36A is associated with kinase activity, Staurosporine can alter its function. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Immunosuppressant which can inhibit calcineurin. By inhibiting calcineurin, it might indirectly influence proteins interacting with Ankyrin repeat domain-containing protein 36A. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
Another calcineurin inhibitor similar to Cyclosporine A. Proteins in association with Ankyrin repeat domain might be affected by changes in calcineurin activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Targets JNK, a kinase which can interact with numerous proteins. If Ankyrin repeat domain-containing protein 36A relies on JNK-related pathways, this compound can exert influence. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor. By altering PI3K pathway activity, proteins in connection with or reliant upon this pathway, possibly including Ankyrin repeat domain-containing protein 36A, might experience changes in their functionality. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which is upstream of ERK. Potential indirect effects on Ankyrin repeat proteins if associated with the MAPK/ERK pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor which can affect protein synthesis and other cellular processes. Might indirectly impact Ankyrin repeat domain-containing protein 36A if it interacts with the mTOR pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
P38 MAPK inhibitor. Could influence Ankyrin repeat domain-containing protein 36A if there's any interaction or reliance on the p38 MAPK pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor like LY294002. Can have indirect effects on proteins interacting with or reliant on the PI3K pathway. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor, involved in influencing cytoskeleton dynamics. If Ankyrin repeat domain-containing protein 36A has any functional association with the cytoskeleton, this inhibitor can play a role. | ||||||